We are live on ! Find out more
GIP

Granite Investment Partners Portfolio holdings

AUM $1.95B
1-Year Est. Return 49.89%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+49.89%
3 Year Est. Return
+130.82%
5 Year Est. Return
+170.12%
10 Year Est. Return
+1,227.59%
AUM
$1.87B
AUM Growth
+$103M
Cap. Flow
+$19.6M
Cap. Flow %
1.05%
Top 10 Hldgs %
16.23%
Holding
382
New
29
Increased
179
Reduced
125
Closed
27

Top Buys

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$15.6M
2
KEM
KEMET Corporation
KEM
+$13.4M
3
APPN icon
Appian
APPN
+$13.1M
4
CDXS icon
Codexis
CDXS
+$10.9M
5
LPSN icon
LivePerson
LPSN
+$10.8M

Top Sells

Rank Stock Value
1
QTS
QTS REALTY TRUST, INC.
QTS
+$16.7M
2
AERI
Aerie Pharmaceuticals
AERI
+$13.3M
3
FIVN icon
FIVE9
FIVN
+$12.2M
4
EFII
Electronics for Imaging
EFII
+$9.96M
5
CRAY
Cray, Inc.
CRAY
+$9.96M

Sector Composition

Rank Sector Weight
1 Technology 18.48%
2 Healthcare 17.3%
3 Industrials 16.63%
4 Financials 9.74%
5 Consumer Discretionary 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
326
Mastercard
MA
$493B
$212K 0.01%
+800
New +$200K
KIN
327
DELISTED
Kindred Biosciences, Inc.
KIN
$211K 0.01%
25,297
-22,208
-47% -$192K
NOC icon
328
Northrop Grumman
NOC
$81.2B
$202K 0.01%
+624
New +$186K
ASPU
329
DELISTED
ASPEN GROUP, INC.
ASPU
$194K 0.01%
50,841
-91,762
-64% -$399K
OPNT
330
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$191K 0.01%
14,453
-12,690
-47% -$154K
NXTP
331
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$190K 0.01%
3,165
-1,148
-27% -$62.9K
RIGL icon
332
Rigel Pharmaceuticals
RIGL
$750M
$188K 0.01%
7,211
-6,333
-47% -$143K
DHX icon
333
DHI Group
DHX
$173M
$187K 0.01%
+52,366
New +$182K
PTY icon
334
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
$184K 0.01%
10,145
-2,506
-20% -$45.1K
POLA icon
335
Polar Power
POLA
$6.86M
$179K 0.01%
6,156
-5,404
-47% -$162K
PIXY
336
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
– –
-1
Closed -$1.06M
APT icon
337
Alpha Pro Tech
APT
$53.6M
$172K 0.01%
50,251
-44,141
-47% -$158K
FAT
338
DELISTED
FAT Brands
FAT
$161K 0.01%
80,158
-140,805
-64% -$323K
CBUS icon
339
Cibus
CBUS
$138M
$145K 0.01%
232
-204
-47% -$152K
ADMS
340
DELISTED
Adamas Pharmaceuticals
ADMS
$141K 0.01%
22,731
-20,004
-47% -$115K
PMD
341
DELISTED
Psychemedics Corporation
PMD
$137K 0.01%
13,528
-11,854
-47% -$135K
SCHZ icon
342
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$110K 0.01%
4,134
– –
FPRX
343
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$104K 0.01%
17,278
-15,164
-47% -$145K
IJH icon
344
iShares Core S&P Mid-Cap ETF
IJH
$127B
$95K 0.01%
2,450
+1,825
+292% +$69.9K
SSY
345
DELISTED
SunLink Health Systems
SSY
$74K ﹤0.01%
50,147
– –
EEM icon
346
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$61K ﹤0.01%
1,421
+206
+17% +$8.74K
IJR icon
347
iShares Core S&P Small-Cap ETF
IJR
$112B
$51K ﹤0.01%
650
+300
+86% +$23.3K
IJT icon
348
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$48K ﹤0.01%
522
+2
+0.4% +$180
IJS icon
349
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
$34K ﹤0.01%
462
+2
+0.4% +$148
EFA icon
350
iShares MSCI EAFE ETF
EFA
$80.2B
$33K ﹤0.01%
500
– –
12 13
14
15 16

Similar funds

FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Granite Investment Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Granite Investment Partners held 382 positions worth $1.87B, up 5.8% from $1.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granite Investment Partners's Q2 2019 filing shows 29 new, 179 increased, 125 reduced and 27 closed positions. Its largest new stake was Core Laboratories: 266,309 shares worth $13.9M. The largest sale was QTS REALTY TRUST, INC., an estimated $16.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Granite Investment Partners's largest Q2 2019 buy was Core Laboratories: 266,309 shares worth $13.9M.
  • Granite Investment Partners added most to LivePerson in Q2 2019, an estimated $10.8M increase.
  • Granite Investment Partners's biggest Q2 2019 reduction was FIVE9, cutting an estimated $12.2M.
  • Granite Investment Partners fully exited QTS REALTY TRUST, INC. in Q2 2019, selling an estimated $16.7M.
  • Granite Investment Partners's ten largest holdings make up 16% of its $1.87B portfolio in Q2 2019.
  • Granite Investment Partners opened 29 new positions and closed 27 in Q2 2019.
  • Granite Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.87B.

Based on Granite Investment Partners's 13F filing for Q2 2019, filed 7 Aug 2019.